StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMAug 4, 2026, 07:27 AM

Theriva Biologics Stockholders Approve Share Plan & Authorized Stock Increase

AI Summary

Theriva Biologics, Inc. held its 2026 Annual Meeting of Stockholders, where several key proposals were approved. Stockholders voted to increase the number of shares authorized under the 2020 Stock Incentive Plan from 4,500,000 to 6,500,000 shares. Additionally, an amendment to increase the number of authorized shares of the Company's common stock was approved, along with the election of four directors and the ratification of BDO USA, P.C. as the independent auditor. The issuance of common stock upon the exercise of outstanding warrants was also approved.

Key Highlights

  • Stockholders approved increasing 2020 Stock Incentive Plan shares from 4.5M to 6.5M.
  • Approved an amendment to increase the number of authorized common shares.
  • Four directors were elected: Jeffrey J. Kraws, Steven A. Shallcross, John Monahan, and Jeffrey Wolf.
  • BDO USA, P.C. was ratified as the independent auditor for the year ending December 31, 2026.
  • Approved the issuance of common stock upon the exercise of outstanding warrants.